Decision making in clinical trials: Interim analyses, innovative design, and biomarkers

The efficient and accurate execution of clinical trials testing novel treatments for Alzheimer's disease (AD) is a critical component of the field's collective efforts to develop effective disease‐modifying treatments for AD. The lengthy and heterogeneous nature of clinical progression in...

Descripción completa

Detalles Bibliográficos
Autores principales: Welsh‐Bohmer, Kathleen A., Kerchner, Geoffrey A., Dhadda, Shobha, Garcia, Miguel, Miller, David S., Natanegara, Fanni, Raket, Lars Lau, Robieson, Weining, Siemers, Eric R., Carrillo, Maria C., Weber, Christopher J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10585126/
https://www.ncbi.nlm.nih.gov/pubmed/37867532
http://dx.doi.org/10.1002/trc2.12421

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10585126/
https://www.ncbi.nlm.nih.gov/pubmed/37867532
http://dx.doi.org/10.1002/trc2.12421

Ejemplares similares